Drown Laura, Adler Alma J, Salvi Devashri, Boudreaux Chantelle, Gupta Neil, Ali Zipporah, Bay Neusa, Chisunka Mukobe, Mulenga Bavin, Koirala Bhagawan, Maharjan Bishwash, Marro Giacomo, Mengistu Zelalem, Mtumbuka Esther, Nabadda Martha, Ruckstuhl Laura, Wurie Ian, Thapa Ada, Mocumbi Ana, Bukhman Gene, Wroe Emily B
Department of Medicine, Center for Integration Science in Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Department of Global Health and Social Medicine, Program in Global Noncommunicable Disease and Social Change, Harvard Medical School, Boston, Massachusetts, United States of America.
PLOS Glob Public Health. 2025 Apr 24;5(4):e0004398. doi: 10.1371/journal.pgph.0004398. eCollection 2025.
Severe chronic noncommunicable diseases (SC-NCDs) are important causes of avoidable disease burden in low- and lower-middle income countries (LLMICs) where care is often available only at tertiary, urban facilities. The Package of Essential Noncommunicable Disease Interventions - Plus (PEN-Plus) strategy aims to address gaps in access to care for SC-NCDs by integrating and decentralizing care. This study aims to assess baseline readiness of 16 facilities in nine LLMICs to provide care for SC-NCDs as part of a mixed-methods evaluation of PEN-Plus implementation. Cross-sectional surveys were utilized to collect baseline data from 16 facilities initiating new PEN-Plus programs. These surveys assessed the state of facility infrastructure and the availability of equipment and medicines for three priority conditions (type 1 diabetes (T1D), sickle cell disease (SCD), severe cardiac conditions (SCC)). Analysis consisted of descriptive statistics and summary index scores based on availability of key items. Facilities reported a high baseline availability of basic infrastructure. Readiness to provide care for priority SC-NCDs varied. Availability of functional diagnostic and management equipment and supplies for T1D was especially low in many facilities but higher for SCD. Medicine availability was overall highest for T1D (75%) but lower for SCD (39%) and SCC (49%), with significant gaps in essential medicines including hydroxyurea, anticoagulants, and medium- or long-lasting insulins.These findings highlight the need for tailored, context-driven implementation approaches to address gaps in readiness for SC-NCD care in LLMICs. Baseline results will guide ongoing implementation and evaluation of the PEN-Plus clinics.
在低收入和中低收入国家(LLMICs),严重慢性非传染性疾病(SC-NCDs)是可避免疾病负担的重要原因,在这些国家,医疗服务往往仅在城市的三级医疗机构提供。基本非传染性疾病综合干预套餐升级版(PEN-Plus)战略旨在通过整合和分散医疗服务来解决SC-NCDs护理可及性方面的差距。本研究旨在评估九个LLMICs中16家医疗机构为SC-NCDs提供护理的基线准备情况,作为对PEN-Plus实施情况进行混合方法评估的一部分。采用横断面调查从16家启动新PEN-Plus项目的医疗机构收集基线数据。这些调查评估了医疗机构基础设施状况以及针对三种优先疾病(1型糖尿病(T1D)、镰状细胞病(SCD)、严重心脏疾病(SCC))的设备和药品可用性。分析包括描述性统计和基于关键项目可用性的综合指数得分。医疗机构报告基本基础设施的基线可用性较高。为优先SC-NCDs提供护理的准备情况各不相同。许多医疗机构中,T1D功能诊断和管理设备及用品的可用性特别低,但SCD的可用性较高。T1D的药品总体可用性最高(75%),但SCD(39%)和SCC(49%)较低,包括羟基脲、抗凝剂和中长效胰岛素在内的基本药物存在显著差距。这些发现凸显了需要采用量身定制、因地制宜的实施方法来解决LLMICs中SC-NCDs护理准备方面的差距。基线结果将指导PEN-Plus诊所的持续实施和评估。